Market Place
Sourcing Support
All News #Library
Others
Alphaton Capital Closes $71M Financing, Completes Ton Token
25 Sep 2025 //
GLOBENEWSWIRE
Portage to Participate in Panel Discussion at the Cantor Healthcare Conference
20 Sep 2023 //
GLOBENEWSWIRE
Portage Hosting Event on Targeting the Adenosine Pathway in Cancer
27 Feb 2023 //
GLOBENEWSWIRE
Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022
29 Nov 2022 //
GLOBENEWSWIRE
Portage Presents Updated Data on the Ph 1/2 Trial Evaluating PORT-2 at (SITC)
10 Nov 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck
08 Nov 2022 //
GLOBENEWSWIRE
Portage Biotech Provides Research and Development Update
14 Sep 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Results for Fiscal Quarter Ended June 30, 2022
29 Aug 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Leadership Updates
18 Aug 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022
01 Aug 2022 //
GLOBENEWSWIRE
Portage acquires adenosine receptor-focused Tarus
08 Jul 2022 //
FIERCEBIOTECH
Portage Biotech Bolsters Pipeline with Acquisition of 4 Candidates
06 Jul 2022 //
GLOBENEWSWIRE
Portage Biotech Summarizes Data Presented at ASCO 2022 from Ongoing PORT-2 Study
06 Jun 2022 //
GLOBENEWSWIRE
Portage Biotech (PRTG) Stock: Why The Price Gained Over 6% Today
23 May 2022 //
PULSE2
Portage Biotech Enters Cooperative R&D Agreement with U.S. National Cancer
25 Apr 2022 //
GLOBENEWSWIRE
portage biotech highlights promising data presented on port-5 at aacr 2022
13 Apr 2022 //
PRESS RELEASE
Portage Bio Presents Data on STING-Activating Therapy, PORT-5 (STI-001) at AACR
13 Apr 2022 //
GLOBENEWSWIRE
Portage Biotech Provides Update on Clinical-Stage and Development Programs
31 Mar 2022 //
GLOBENEWSWIRE
Portage Biotech says Presentation of PORT-5 (STI-001) Late-Breaking Data
09 Mar 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Q3 Financial Results and Provides Business Update
24 Feb 2022 //
GLOBENEWSWIRE
Portage Biotech Announces Financial Results and Provides Business
23 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech to Present at the Piper Sandler 33rd AHC
22 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech Highlights Promising Efficacy and Survival Data
15 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech Hosting Key Opinion Leader Webinar on How iNKT Agonists
10 Nov 2021 //
GLOBENEWSWIRE
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
30 Aug 2021 //
GLOBENEWSWIRE
Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2
05 Aug 2021 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.